Background Uric acid is the end product of the purine metabolism pathway, and has been
linked to cancer risks and prognosis, but its relationship with hepatoblastoma (HB) remains …

Abstract Background The Apolipoprotein-related MORtality RISk (AMORIS) study in Sweden
revealed that serum uric acid (SUA) was significantly associated with hepatobiliary cancer …

Purpose Uric acid (UA) plays a dual role as an antioxidant and a prooxidant in patients with
malignant tumors; however, the relationship between serum UA and malignancy is currently …

Background: Hepatocellular carcinoma (HCC) is regarded as one of the most common
cancers in the world with a poor prognosis. Patients with HCC often have abnormal purine …

Background: Recent evidence indicates toward a role of uric acid (UA) as a potential
antioxidant. Elevated UA levels were shown to be associated with better survival in various …

BACKGROUND Uric acid is the end product of purine metabolism. Previous studies have
found that serum uric acid (SUA) levels are associated with the total cancer risk. However …

Background Recently, chemical blood parameters gain more attraction as potential
prognostic parameters in pancreatic cancer (PC). In the present study we investigated the …

Objective: Serum uric acid is associated with tumor progression and hepatocarcinogenesis.
Here, we aimed to determine whether serum uric acid is related to the survival time of …

Background and Aim: Uric acid is the final product of purine metabolism. Previous studies
have found that uric acid not only can act as a scavenger of reactive oxygen species and …

Hepatocellular carcinoma (HCC) is highly malignant; nearly half of the new cases and
deaths are in China. The poor prognosis of HCC is mainly due to late diagnosis; many new …